Under construction – not a live service
Sign in
Taking people in United StatesNo phase

Targeted TDCS to Enhance Speech-Language Treatment Outcome in Persons With Chronic Post-Stroke Aphasia.

Key facts

Where
Albuquerque, United StatesSee the site

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 25 and 85 years old?

Source: NCT04432883, who can take part

Where in United States

  • University of New Mexico Center for Brain Recovery and RepairAlbuquerque, United StatesTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
University of New Mexico
Trial code
NCT04432883
Record updated
22 May 2026
Original description
62 patients who are one year post stroke and have Aphasia as a result of that stroke will be recruited. Participants will have 4 assessment sessions and 15 treatment sessions. The TDCS will be to right Inferior Frontal Gyrus (IFG) (25 active, 25 sham) for 15 days. A combined semantic feature analysis/phonological components analysis treatment will be paired with the stimulation. Two assessment sessions will be pretreatment, 1 session immediately post-treatment, and 1 session at 3 months follow-up.Read full original descriptionShow less

Targeted Transcranial Direct Current Stimulation to Enhance Speech-Language Treatment Outcome in Persons With Chronic Post-Stroke Aphasia

62 patients who are one year post stroke and have Aphasia as a result of that stroke will be recruited. Participants will have 4 assessment sessions and 15 treatment sessions. The TDCS will be to right Inferior Frontal Gyrus (IFG) (25 active, 25 sham) for 15 days. A combined semantic feature analysis/phonological components analysis treatment will be paired with the stimulation. Two assessment sessions will be pretreatment, 1 session immediately post-treatment, and 1 session at 3 months follow-up.

Inclusion: aged 25-85; must be greater than 6 months post-stroke; must have a diagnosis of aphasia based on impaired performance on the Western Aphasia Battery-Revised, Boston Naming Test, or during discourse production; must be left-hemisphere dominant as demonstrated by aphasia onset subsequent to left hemisphere damage; must be stimulable for naming.

Exclusion: comorbid neurological disease; significant mood disorder; damage to the anterior right hemisphere; substance/alcohol dependence or abuse within the past year; presence of any implanted electrical device or contraindications to tDCS or MRI; recent medical instability (within 4 weeks); pregnancy.

ClinicalTrials.gov NCT04432883